Stock Research: Mega Lifesciences

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Mega Lifesciences

SET:MEGA TH4984010009
100
  • Value
    54
  • Growth
    81
  • Safety
    Safety
    86
  • Combined
    94
  • Sentiment
    78
  • 360° View
    360° View
    100
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

ANALYSIS: With an Obermatt 360° View of 100 (better than 100% compared with alternatives) for 2026, overall professional sentiment and financial characteristics for the stock Mega Lifesciences are very positive. The 360° View is based on consolidating four consolidated indicators, with all four indicators above average for Mega Lifesciences. The consolidated Value Rank has an attractive rank of 54, which means that the share price of Mega Lifesciences is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 54% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 81, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. The company is also safely financed with a Safety rank of 86. Finally, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 78. ...read more

more
Index
SET
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 13-Mar-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
54 n/a n/a n/a
Growth
81 n/a n/a n/a
Safety
Safety
86 n/a n/a n/a
Sentiment
78 n/a n/a n/a
360° View
360° View
100 n/a n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
52 n/a n/a n/a
Opinions Change
50 n/a n/a n/a
Pro Holdings
n/a n/a n/a n/a
Market Pulse
50 n/a n/a n/a
Sentiment
78 n/a n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
54 n/a n/a n/a
Growth
81 n/a n/a n/a
Safety Safety
86 n/a n/a n/a
Combined
94 n/a n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
26 n/a n/a n/a
Price vs. Earnings (P/E)
52 n/a n/a n/a
Price vs. Book (P/B)
22 n/a n/a n/a
Dividend Yield
87 n/a n/a n/a
Value
54 n/a n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
39 n/a n/a n/a
Profit Growth
75 n/a n/a n/a
Capital Growth
77 n/a n/a n/a
Stock Returns
67 n/a n/a n/a
Growth
81 n/a n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
69 n/a n/a n/a
Refinancing
57 n/a n/a n/a
Liquidity
82 n/a n/a n/a
Safety Safety
86 n/a n/a n/a

Similar Stocks

Discover high‑ranked alternatives to Mega Lifesciences and broaden your portfolio horizons.

Sri Trang Gloves (Thailand)

SET:STGT
Country: Thailand
Industry: Health Care Supplies
Size: Medium
Full Stock Analysis

Kalbe Farma

JKT:KLBF
Country: Indonesia
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

PTT

SET:PTT
Country: Thailand
Industry: Oil & Gas Integrated
Size: XX-Large
Full Stock Analysis

Gunkul Engineering

SET:GUNKUL
Country: Thailand
Industry: Renewable Electricity
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

This is an all-around strong stock. It shows good value, high growth, safe financing, and positive professional sentiment. It is ideal for most buy-and-hold investors who value a good all-around stock.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: